PREGNA-1,4,17(20)-TRIEN-21-AL, 11,20-DIHYDROXY-6-METHYL-3-OXO-, (6.ALPHA.,11.BETA.)-, (E)-
UNII KQY3U4DAB7
Substance Identification & Data
This profile provides standardized clinical and technical data for Pregna-1,4,17(20)-trien-21-al, 11,20-dihydroxy-6-methyl-3-oxo-, (6.alpha.,11.beta.)-, (e)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KQY3U4DAB7.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H28O4 XYGYYRSXRDASPZ-WRKVFVSJSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Pregna-1,4,17(20)-trien-21-al, 11,20-dihydroxy-6-methyl-3-oxo-, (6.alpha.,11.beta.)-, (e)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.